Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
ILR-H525x | Human | Human IL-7 R alpha&TSLP R Heterodimer Protein, Fc Tag&Fc Tag | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
ILR-H5255 | Human | Human IL-7 R alpha&TSLP R Heterodimer Protein, Fc Tag&Fc Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
Loaded Human IL-7 RA&TSLP R Heterodimer Protein, Fc Tag&Fc Tag (Cat. No. ILR-H525x) on Protein A Biosensor, can bind Human TSLP, His Tag (Cat. No. TSP-H52Hb) with an affinity constant of 1.16 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
PF-06342674 | RN-168; PF-6342674; PF-06342674 | Pfizer Inc | Details | ||
ASP-9801 | ASP-9801 | Phase 1 Clinical | Astellas Pharma Inc | Solid tumours | Details |
Efineptakin alfa | NT-I7; GX-I7; TJ-107 | Phase 2 Clinical | Genexine Inc | Pancreatic Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Laryngeal Neoplasms; Carcinoma, Squamous Cell; Glioma; Oropharyngeal Neoplasms; Lymphopenia; Colorectal Neoplasms; Leukopenia; Breast Neoplasms; Urinary Bladder Neoplasms; Ovarian Neoplasms; Triple Negative Breast Neoplasms; Hypopharyngeal Neoplasms; Small Cell Lung Carcinoma; Papillomavirus Infections; Glioblastoma; Coronavirus Disease 2019 (COVID-19); Carcinoma, Merkel Cell; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Solid tumours | Details |
Lusvertikimab | OSE-127; S-95011 | Phase 2 Clinical | Effimune | Sjogren's Syndrome; Colitis, Ulcerative | Details |
Interleukin-7 (Revimmune SAS) | rhIL-7; CYT-107; CYT-99-007 | Phase 2 Clinical | Cytheris | HIV Infections; Kidney Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Shock, Septic; Hepatitis B, Chronic; Coronavirus Disease 2019 (COVID-19); Sepsis; Mycobacterium Infections, Nontuberculous; Myeloproliferative Disorders; Breast Neoplasms; Lymphopenia; Hepatitis C; Leukemia, Myeloid, Acute; Melanoma | Details |
MDK-703 | MDK-703 | Phase 1 Clinical | Details |
This web search service is supported by Google Inc.